Table 3.
Study | Adjusted factors |
---|---|
Lee et al. [32] | Age, BMI, sex, tumour size, cellular grade, and pathologic stage |
Antonelli et al. [25] | Age, sex, tumour size, pathologic stage, and surgical margin status |
Cai et al. [26] | Age, ASA score, and pathologic stage |
Dash et al. [27] | Age, grade, stage, tumour size, and vascular invasion |
Jang et al. [30] | Age, sex, comorbidities, BMI, tumour size and depth, histologic type, and preoperative eGFR |
Milonas et al. [33] | Age, tumour size, pathologic stage, ASA score, and tumour grade |
Thompson et al. [34] | Age, CCI, pathologic stage, tumour size, histological subtype, and chronic kidney disease |
Weight et al. [22] | Age, tumour size, presence of contralateral disease, solitary kidney status, and CCI |
Roos et al. [19] | Age, symptoms at presentation, type of surgery, tumour size, and ASA score |
ASA score, American Society of Anesthesiologists score; CCI, Charlson comorbidity index; ECOG score, Eastern Cooperative Oncology Group score; BMI, body mass index; eGFR, estimated glomerular filtration rate.